ZA96525B - Novel pharmaceutical compositions - Google Patents
Novel pharmaceutical compositionsInfo
- Publication number
- ZA96525B ZA96525B ZA96525A ZA96525A ZA96525B ZA 96525 B ZA96525 B ZA 96525B ZA 96525 A ZA96525 A ZA 96525A ZA 96525 A ZA96525 A ZA 96525A ZA 96525 B ZA96525 B ZA 96525B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical compositions
- novel pharmaceutical
- novel
- compositions
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9500113 | 1995-02-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA96525B true ZA96525B (en) | 1996-08-06 |
Family
ID=20396819
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA96525A ZA96525B (en) | 1995-02-06 | 1996-01-23 | Novel pharmaceutical compositions |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6117857A (sv) |
| EP (1) | EP0810865A1 (sv) |
| JP (1) | JPH11504313A (sv) |
| KR (1) | KR19980701957A (sv) |
| AR (1) | AR002029A1 (sv) |
| AU (1) | AU713229B2 (sv) |
| CA (1) | CA2211464A1 (sv) |
| FI (1) | FI973229A (sv) |
| IL (1) | IL116912A0 (sv) |
| NO (1) | NO973610L (sv) |
| NZ (1) | NZ301405A (sv) |
| WO (1) | WO1996024354A1 (sv) |
| ZA (1) | ZA96525B (sv) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9800729L (sv) * | 1998-03-06 | 1999-09-07 | Scotia Lipidteknik Ab | Ny topikal formulering I |
| SE515982C2 (sv) * | 1998-03-06 | 2001-11-05 | Lipocore Holding Ab | Användning av en olja-i-vatten emulsion som bärare för framställning av en topikal kräm eller lotion |
| FR2814071A1 (fr) * | 2000-09-21 | 2002-03-22 | Oreal | Composition a base de glycoglyceride et ses utilisations notamment cosmetiques |
| US6960346B2 (en) * | 2002-05-09 | 2005-11-01 | University Of Tennessee Research Foundation | Vehicles for delivery of biologically active substances |
| AU2003272536A1 (en) * | 2002-09-18 | 2004-04-08 | Emiliano Ghinelli | Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin |
| JP2006520374A (ja) * | 2003-03-14 | 2006-09-07 | エピスタム リミテッド | 非ウィルス性上皮損傷の治療および／または予防 |
| SE0400233D0 (sv) * | 2004-02-04 | 2004-02-04 | Ltp Lipid Technologies Provide | Rektal komposition |
| SE0401942D0 (sv) * | 2004-07-28 | 2004-07-28 | Lipopeptide Ab | New antimicrobial peptide complexes |
| JP2008534602A (ja) * | 2005-03-30 | 2008-08-28 | ノバルティス アクチエンゲゼルシャフト | １日適用での再発性性器ヘルペスの処置のためのペンシクロビル |
| US20100136106A1 (en) * | 2005-06-08 | 2010-06-03 | Gary Liversidge | Modified Release Famciclovir Compositions |
| US8236768B2 (en) | 2008-10-03 | 2012-08-07 | 3B Pharmaceuticals, Inc. | Topical antiviral formulations |
| IT1398268B1 (it) * | 2009-03-10 | 2013-02-22 | Prigen Srl | Glicerosomi e loro impiego in preparazioni farmaceutiche e cosmetiche per uso topico |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0009842B1 (en) * | 1978-10-02 | 1982-11-10 | THE PROCTER & GAMBLE COMPANY | Liposomes for drug delivery and composition containing a liposome drug system |
| CA1320130C (en) * | 1986-06-12 | 1993-07-13 | Alan L. Weiner | Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs |
| WO1989005152A1 (en) * | 1987-12-09 | 1989-06-15 | The Regents Of The University Of California | Liposome-encapsulated anti-viral composition and method |
| US5194654A (en) * | 1989-11-22 | 1993-03-16 | Vical, Inc. | Lipid derivatives of phosphonoacids for liposomal incorporation and method of use |
| DK169121B1 (da) * | 1992-09-09 | 1994-08-22 | Gea Farmaceutisk Fabrik As | Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf |
| IL104283A (en) * | 1992-12-30 | 1996-12-05 | Agis Ind 1983 Ltd | Non-emulsion antiviral topical pharmaceutical composition comprising acyclovir an aqueous gel agent and an alkali oleate |
| GB9315755D0 (en) * | 1993-07-30 | 1993-09-15 | Wellcome Found | Stabilized formulation |
-
1996
- 1996-01-23 ZA ZA96525A patent/ZA96525B/xx unknown
- 1996-01-26 IL IL11691296A patent/IL116912A0/xx unknown
- 1996-02-02 WO PCT/SE1996/000122 patent/WO1996024354A1/en not_active Application Discontinuation
- 1996-02-02 US US08/605,057 patent/US6117857A/en not_active Expired - Fee Related
- 1996-02-02 JP JP8524187A patent/JPH11504313A/ja active Pending
- 1996-02-02 CA CA002211464A patent/CA2211464A1/en not_active Abandoned
- 1996-02-02 AU AU46819/96A patent/AU713229B2/en not_active Ceased
- 1996-02-02 EP EP96902555A patent/EP0810865A1/en not_active Withdrawn
- 1996-02-02 KR KR1019970705354A patent/KR19980701957A/ko not_active Application Discontinuation
- 1996-02-05 AR ARP960101277A patent/AR002029A1/es unknown
- 1996-02-14 NZ NZ301405A patent/NZ301405A/xx unknown
-
1997
- 1997-08-05 NO NO973610A patent/NO973610L/no unknown
- 1997-08-05 FI FI973229A patent/FI973229A/sv unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO973610L (no) | 1997-09-26 |
| FI973229A0 (sv) | 1997-08-05 |
| AU4681996A (en) | 1996-08-27 |
| EP0810865A1 (en) | 1997-12-10 |
| AU713229B2 (en) | 1999-11-25 |
| FI973229A (sv) | 1997-08-05 |
| JPH11504313A (ja) | 1999-04-20 |
| AR002029A1 (es) | 1998-01-07 |
| NZ301405A (en) | 1999-01-28 |
| WO1996024354A1 (en) | 1996-08-15 |
| US6117857A (en) | 2000-09-12 |
| NO973610D0 (no) | 1997-08-05 |
| CA2211464A1 (en) | 1996-08-15 |
| IL116912A0 (en) | 1996-07-23 |
| KR19980701957A (ko) | 1998-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9601698D0 (en) | Pharmaceutical composition | |
| HUP9602056A2 (en) | Novel pharmaceutical composition containing phenofibrate | |
| ZA967827B (en) | Pharmaceutical compositions | |
| GB9623205D0 (en) | Novel pharmaceutical compositions | |
| EP0755250A4 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING BENZAMIDE | |
| GB9519667D0 (en) | Pharmaceutical composition | |
| ZA962214B (en) | Pharmaceutical composition | |
| EG24294A (en) | Pharmaceutical compositions | |
| ZA963590B (en) | Pharmaceutical composition | |
| GB9506382D0 (en) | Pharmaceutical compositions | |
| ZA96525B (en) | Novel pharmaceutical compositions | |
| GB9513972D0 (en) | Pharmaceutical compositions | |
| ZA961051B (en) | Pharmaceutical composition | |
| ZA9610426B (en) | Pharmaceutical composition | |
| ZA964193B (en) | Pharmaceutical composition | |
| GB2295825B (en) | Pharmaceutical compositions | |
| ZA963591B (en) | Pharmaceutical composition | |
| ZA968616B (en) | Pharmaceutical composition | |
| GB2308545A (en) | Pharmaceutical compositions | |
| ZA95736B (en) | Pharmaceutical composition | |
| HUP9602732A3 (en) | Pharmaceutical composition comprising lanperisone | |
| GB9506301D0 (en) | Pharmaceutical compositions | |
| GB9517133D0 (en) | Pharmaceutical compositions | |
| GB9519157D0 (en) | Pharmaceutical compositions | |
| HU0500763D0 (en) | Pharmaceutical compositions |